155 related articles for article (PubMed ID: 21106109)
1. Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas.
Jia Y; Wang Y; Chao Y; Jing Y; Sun Z; Luo B
Virol J; 2010 Nov; 7():341. PubMed ID: 21106109
[TBL] [Abstract][Full Text] [Related]
2. Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas.
Yang Y; Jia Y; Wang Y; Wang X; Sun Z; Luo B
J Med Virol; 2014 Oct; 86(10):1788-95. PubMed ID: 24615673
[TBL] [Abstract][Full Text] [Related]
3. Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma.
Zhang JB; Huang SY; Wang TM; Dong SQ; He YQ; Zheng XH; Li XZ; Wang F; Jianbing M; Jia WH
EBioMedicine; 2018 Nov; 37():101-109. PubMed ID: 30420297
[TBL] [Abstract][Full Text] [Related]
4. Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China.
Luo B; Tang X; Jia Y; Wang Y; Chao Y; Zhao C
Microbes Infect; 2011 Aug; 13(8-9):776-82. PubMed ID: 21527354
[TBL] [Abstract][Full Text] [Related]
5. Expression of Epstein-Barr virus lytic gene BRLF1 in nasopharyngeal carcinoma: potential use in diagnosis.
Feng P; Ren EC; Liu D; Chan SH; Hu H
J Gen Virol; 2000 Oct; 81(Pt 10):2417-2423. PubMed ID: 10993929
[TBL] [Abstract][Full Text] [Related]
6. Use of adenovirus vectors expressing Epstein-Barr virus (EBV) immediate-early protein BZLF1 or BRLF1 to treat EBV-positive tumors.
Feng WH; Westphal E; Mauser A; Raab-Traub N; Gulley ML; Busson P; Kenney SC
J Virol; 2002 Nov; 76(21):10951-9. PubMed ID: 12368338
[TBL] [Abstract][Full Text] [Related]
7. Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas.
Wang X; Wang Y; Wu G; Chao Y; Sun Z; Luo B
Virol J; 2012 Feb; 9():49. PubMed ID: 22348267
[TBL] [Abstract][Full Text] [Related]
8. Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates.
Wang X; Liu X; Jia Y; Chao Y; Xing X; Wang Y; Luo B
J Gen Virol; 2010 Oct; 91(Pt 10):2564-73. PubMed ID: 20554797
[TBL] [Abstract][Full Text] [Related]
9. Characterization of Epstein-Barr virus-encoded small RNA gene variations in virus associated lymphomas in Northern China.
Zhao Z; Sun L; Liu S; Shu J; Luo B
Arch Virol; 2017 Jun; 162(6):1609-1616. PubMed ID: 28220325
[TBL] [Abstract][Full Text] [Related]
10. Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies.
Wang Y; Wang XF; Sun ZF; Luo B
Virus Res; 2012 Jun; 166(1-2):23-30. PubMed ID: 22406129
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional activation of Epstein-Barr virus BRLF1 by USF1 and Rta.
Hung CC; Kuo CW; Wang WH; Chang TH; Chang PJ; Chang LK; Liu ST
J Gen Virol; 2015 Sep; 96(9):2855-2866. PubMed ID: 26297580
[TBL] [Abstract][Full Text] [Related]
12. Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China.
Chen JN; Zhang NN; Jiang Y; Hui DY; Wen ZJ; Li HG; Ding YG; Du H; Shao CK
PLoS One; 2012; 7(11):e50084. PubMed ID: 23189182
[TBL] [Abstract][Full Text] [Related]
13. Sequence analysis of EBV immune evasion gene BNLF2a in EBV associated tumors and healthy individuals from nasopharyngeal carcinoma endemic and non-endemic regions of China.
Liu S; Wang X; Shu J; Zhao Z; Sun Z; Luo B
J Med Virol; 2015 Nov; 87(11):1946-52. PubMed ID: 25959517
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China.
Wu G; Wang Y; Chao Y; Jia Y; Zhao C; Luo B
Arch Virol; 2012 May; 157(5):845-53. PubMed ID: 22302288
[TBL] [Abstract][Full Text] [Related]
15. Methylation profiling of Epstein-Barr virus immediate-early gene promoters, BZLF1 and BRLF1 in tumors of epithelial, NK- and B-cell origins.
Li L; Su X; Choi GC; Cao Y; Ambinder RF; Tao Q
BMC Cancer; 2012 Mar; 12():125. PubMed ID: 22458933
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP.
Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J
J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396
[TBL] [Abstract][Full Text] [Related]
17. Cellular transcription factor Oct-1 interacts with the Epstein-Barr virus BRLF1 protein to promote disruption of viral latency.
Robinson AR; Kwek SS; Hagemeier SR; Wille CK; Kenney SC
J Virol; 2011 Sep; 85(17):8940-53. PubMed ID: 21697476
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient.
Nie Y; Sun Y; Wang Y; Liu C; Zhao C; Luo B
Arch Virol; 2013 May; 158(5):1031-7. PubMed ID: 23266831
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr Virus BRLF1 Induces PD-L1 Expression in Nasopharyngeal Carcinoma Cells.
Wu CC; Chen MS; Lee TY; Huang TS; Cho DY; Chen JY
Viral Immunol; 2024 Mar; 37(2):115-123. PubMed ID: 38498796
[TBL] [Abstract][Full Text] [Related]
20. Amino acid substitutions reveal distinct functions of serine 186 of the ZEBRA protein in activation of early lytic cycle genes and synergy with the Epstein-Barr virus R transactivator.
Francis A; Ragoczy T; Gradoville L; Heston L; El-Guindy A; Endo Y; Miller G
J Virol; 1999 Jun; 73(6):4543-51. PubMed ID: 10233912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
